Go Pro
→ The ultimate IPO unicorn (From Weiss Ratings) (Ad)tc pixel Free DMRA Stock Alerts

Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest Ratio & Short Volume

Damora Therapeutics, Inc. Common Stock logo
$29.54 -0.38 (-1.27%)
As of 04:00 PM Eastern
Compare

Damora Therapeutics, Inc. Common Stock Short Interest Overview

As of July 15, 2026, Damora Therapeutics, Inc. Common Stock (DMRA) had a short interest of 4.69 million shares sold short, representing 7.65% of the public float. This marks a 31.40% increase in short interest since the prior report. The short interest ratio (days to cover) is 8.1, meaning it would take 8.1 days of the average trading volume of 388,762 shares to cover all short positions.

Current Short Interest
4,688,241 shares
Previous Short Interest
3,567,900 shares
Change Vs. Previous Month
31.40%
Dollar Volume Sold Short
$145.10 million
Short Interest Ratio
8.1 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
61,550,000 shares
Short Percent of Float
7.65%
Today's Trading Volume
216,195 shares
Average Trading Volume
388,762 shares
Today's Volume Vs. Average
56%
Short Selling Damora Therapeutics, Inc. Common Stock?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Damora Therapeutics, Inc. Common Stock and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DMRA Short Interest Over Time

DMRA Days to Cover Over Time

DMRA Percentage of Float Shorted Over Time

Damora Therapeutics, Inc. Common Stock Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20264,688,241 shares $145.10 million +31.4%7.6%8.08 $30.95
6/30/20263,567,900 shares $92.80 million +172.3%5.8%2.63 $26.01
6/15/20261,310,364 shares $26.30 million -6.6%2.1%3.37 $20.07
5/29/20261,402,988 shares $34.91 million +8.7%2.3%4.14 $24.88
5/15/20261,290,741 shares $31.75 million +8.4%2.1%3.09 $24.60
4/30/20261,191,070 shares $30.56 million +6.7%2.0%5.51 $25.66
4/15/20261,116,620 shares $29.71 million +35.0%1.8%4.72 $26.61
3/31/2026827,221 shares $21.43 million +93.4%1.3%2.46 $25.90
3/13/2026427,713 shares $12.19 million +31.6%0.8%1.94 $28.50
2/27/2026325,076 shares $9.62 million +17.4%22.7%1.13 $29.58
2/13/2026277,004 shares $8.07 million +86.6%19.4%0.6 $29.12
1/30/2026148,474 shares $3.90 million -12.3%10.4%4.56 $26.24
1/15/2026169,350 shares $4.06 million -1.8%11.8%6.28 $23.95
12/31/2025172,444 shares $3.97 million -4.8%12.1%2.31 $23.01
12/15/2025181,086 shares $5.72 million +8.1%12.7%1.15 $31.60
11/28/2025167,465 shares $2.90 million -50.4%14.1%0.8 $17.35
11/14/2025337,430 shares $9.05 million +920.8%28.5%0.05 $26.83
10/31/202533,054 shares $241.96 thousand -62.9%2.8%0.33 $7.32
10/15/202589,100 shares $1.04 million -32.1%7.1%0 $11.68
9/30/2025131,200 shares $488.06 thousand +57.7%11.3%0.1 $3.72
9/15/202583,200 shares $235.46 thousand +560.3%7.3%0.1 $2.83
8/31/202512,600 shares $40.02 thousand -34.4%1.1%0.1 $3.18
8/15/202519,200 shares $65.38 thousand -30.2%1.7%0.9 $3.41
7/31/202527,500 shares $90.61 thousand -30.6%2.4%0.6 $3.30
7/15/202539,600 shares $140.58 thousand +7.3%3.5%0.9 $3.55
6/30/202536,900 shares $125.83 thousand -18.0%3.2%0.8 $3.41
6/15/202545,000 shares $150.75 thousand -40.4%4.0%0.5 $3.35
5/31/202575,500 shares $234.81 thousand +36.3%6.6%0.3 $3.11
5/15/202555,400 shares $161.21 thousand -20.4%4.9%0.2 $2.91
4/30/202569,600 shares $194.88 thousand +20.8%6.1%0.3 $2.80
4/15/202557,600 shares $148.03 thousand -11.0%5.1%0.2 $2.57
3/31/202564,700 shares $200.57 thousand +133.6%5.7%0.3 $3.10
3/15/202527,700 shares $112.19 thousand +51.4%2.4%0.1 $4.05
2/28/202518,300 shares $80.15 thousand -10.3%1.6%1 $4.38
2/15/202520,400 shares $97.51 thousand +56.9%1.8%1 $4.78
1/31/202513,000 shares $65 thousand -27.4%1.1%0.7 $5.00
1/15/202517,900 shares $86.28 thousand +6.6%1.6%0.9 $4.82
12/31/202416,800 shares $78.12 thousand -30.9%1.5%0.8 $4.65
12/15/202424,300 shares $123.44 thousand +20.3%2.1%0.9 $5.08
11/30/202420,200 shares $107.06 thousand +112.6%1.8%0.7 $5.30
Trump’s New Currency Reset (Ad)

Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel

Watch the documentary briefing and find out which side you land on
11/15/20249,500 shares $60.42 thousand +97.9%0.8%0.2 $6.36
10/31/20244,800 shares $32.88 thousand -48.9%0.4%0.1 $6.85
10/15/20249,400 shares $63.26 thousand -36.1%0.9%0.3 $6.73
9/30/202414,700 shares $178.61 thousand +129.7%1.4%0.5 $12.15
9/15/20246,400 shares $82.75 thousand -62.1%0.6%0.3 $12.93
8/31/202416,900 shares $201.96 thousand +98.8%1.9%1 $11.95
8/15/20248,500 shares $4.68 thousand +3.7%0.0%0.1 $0.55
7/31/20248,200 shares $4.62 thousand +173.3%0.0%0.1 $0.56
7/15/20243,000 shares $1.77 thousand -90.3%0.0%0 $0.59
6/30/202430,800 shares $14.61 thousand +1,084.6%0.2%0.2 $0.47
6/15/20242,600 shares $1.38 thousand -72.0%0.0%0 $0.53
5/31/20249,300 shares $5.65 thousand -80.4%0.1%0.1 $0.61
5/15/202447,400 shares $30.14 thousand -44.4%0.2%0.3 $0.64
4/30/202485,300 shares $58.77 thousand +373.9%0.4%0.4 $0.69
4/15/202418,000 shares $12.37 thousand -42.9%0.1%0.1 $0.69
3/31/202431,500 shares $24.57 thousand +74.0%0.2%0.1 $0.78
3/15/202418,100 shares $14.80 thousand -66.9%0.1%0 $0.82
2/29/202454,600 shares $39.32 thousand +39.6%0.3%0.1 $0.72
2/15/202439,100 shares $26.60 thousand -40.5%0.2%0.1 $0.68
1/31/202465,700 shares $40.21 thousand -53.0%0.3%0.2 $0.61
1/15/2024139,800 shares $96.18 thousand -54.3%0.7%0.4 $0.69
12/31/2023306,000 shares $220.32 thousand +332.2%1.6%0.8 $0.72
12/15/202370,800 shares $43.05 thousand -61.4%0.4%0.1 $0.61
11/30/2023183,400 shares $115.54 thousand -26.1%1.0%0.4 $0.63
11/15/2023248,000 shares $152.05 thousand -46.5%1.3%0.5 $0.61
10/31/2023463,900 shares $245.91 thousand -32.6%2.4%0.7 $0.53
10/15/2023688,500 shares $425.15 thousand -53.8%3.5%0.9 $0.62
9/30/20231,490,000 shares $1.07 million +337.5%7.0%2 $0.72
9/15/2023340,600 shares $201.87 thousand +95.8%1.6%0.7 $0.59
8/31/2023174,000 shares $105.27 thousand -55.9%0.8%0.4 $0.61
8/15/2023394,500 shares $265.70 thousand +73.0%2.0%1 $0.67
7/31/2023228,100 shares $702.55 thousand +403.5%1.2%1.3 $3.08
7/15/202345,300 shares $108.72 thousand -4.0%0.3%0.4 $2.40
6/30/202347,200 shares $118.94 thousand +271.7%0.3%0.7 $2.52
6/15/202312,700 shares $27.94 thousand +4.1%0.1%0.2 $2.20
5/31/202312,200 shares $26.60 thousand +3.4%0.1%0.2 $2.18
5/15/202311,800 shares $25.25 thousand -3.3%0.1%0.2 $2.14
4/30/202312,200 shares $21.47 thousand -63.8%0.1%0.2 $1.76
4/15/202333,700 shares $64.03 thousand +163.3%0.2%0.7 $1.90
3/31/202312,800 shares $25.47 thousand -25.6%0.1%0.3 $1.99
3/15/202317,200 shares $31.99 thousand -51.6%0.1%0.3 $1.86
2/28/202335,500 shares $77.75 thousand -47.6%0.2%0.7 $2.19
2/15/202367,700 shares $176.70 thousand +35.4%0.4%1.2 $2.61
1/31/202350,000 shares $115.00 thousand -40.7%0.3%0.8 $2.30
1/15/202384,300 shares $182.09 thousand +28.9%0.5%1.3 $2.16
12/30/202265,400 shares $75.21 thousand +127.9%0.4%1.1 $1.15
12/15/202228,700 shares $40.47 thousand +25.3%0.2%0.5 $1.41
11/30/202222,900 shares $35.95 thousand +2.7%0.1%0.4 $1.57
11/15/202222,300 shares $40.14 thousand -0.5%0.1%0.3 $1.80
10/31/202222,400 shares $45.02 thousand -47.5%0.1%0.3 $2.01
Bernie is gunning for your money (Ad)

Bernie Sanders introduced a bill proposing a one-time 50% tax on shares of America's most successful companies - not on profits or revenue, but on the equity itself. Trump has now backed the same sovereign wealth fund concept, and the U.S. government already owns stakes in 37 companies worth $27.6 billion. A Silicon Valley doctrine may be behind the push, redirecting capital at massive scale toward a small group of firms.tc pixel

Watch the full interview to see what to buy and sell
10/15/202242,700 shares $81.34 thousand -17.3%0.3%0.7 $1.91
9/30/202251,600 shares $97.52 thousand +32.3%0.3%0.9 $1.89
9/15/202239,000 shares $95.16 thousand -14.5%0.2%0.7 $2.44
8/31/202245,600 shares $98.04 thousand -9.7%0.3%0.8 $2.15
8/15/202250,500 shares $108.58 thousand -0.4%0.3%0.5 $2.15
7/31/202250,700 shares $81.63 thousand -11.1%0.3%0.5 $1.61
7/15/202257,000 shares $100.32 thousand +325.4%0.4%0.5 $1.76
6/30/202213,400 shares $23.18 thousand -68.2%0.1%0.1 $1.73
6/15/202242,100 shares $73.68 thousand -17.8%0.3%0.4 $1.75
5/31/202251,200 shares $67.07 thousand +85.5%0.3%0.4 $1.31
5/15/202227,600 shares $39.19 thousand +17.0%0.3%0.4 $1.42
4/30/202223,600 shares $39.65 thousand -60.9%0.2%0.4 $1.68
4/15/202260,300 shares $151.35 thousand +1.3%0.6%0.9 $2.51
3/31/202259,500 shares $130.90 thousand -35.0%0.6%0.8 $2.20
3/15/202291,500 shares $167.45 thousand +37.6%0.9%0.9 $1.83
2/28/202266,500 shares $123.03 thousand -26.4%0.6%0.5 $1.85
2/15/202290,300 shares $190.53 thousand -24.0%0.8%0.7 $2.11
1/31/2022118,800 shares $285.12 thousand +52.3%1.3%0.7 $2.40
1/15/202278,000 shares $188.76 thousand -41.7%N/A0 $2.42
12/31/2021133,700 shares $405.11 thousand +188.2%1.4%0.7 $3.03
12/15/202146,400 shares $110.43 thousand -16.3%0.5%0.2 $2.38
11/30/202155,400 shares $156.23 thousand -0.7%0.6%0.4 $2.82
11/15/202155,800 shares $195.86 thousand -21.9%0.6%0.4 $3.51
10/29/202171,400 shares $235.62 thousand +152.3%0.8%0.4 $3.30
10/15/202128,300 shares $96.79 thousand -41.4%0.3%0.2 $3.42
9/30/202148,300 shares $173.40 thousand -42.0%0.5%0.3 $3.59
9/15/202183,200 shares $348.61 thousand -16.6%0.9%0.3 $4.19
8/31/202199,700 shares $443.67 thousand -26.2%1.1%0.1 $4.45
8/13/2021135,100 shares $559.31 thousand -26.7%1.4%0.1 $4.14

DMRA Short Interest - Frequently Asked Questions

Short interest is the volume of Damora Therapeutics, Inc. Common Stock shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 4,688,241 shares of DMRA short. 7.65% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Learn More on Damora Therapeutics, Inc. Common Stock's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMRA shares currently have a short interest ratio of 8.1. Learn More on Damora Therapeutics, Inc. Common Stock's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.65% of Damora Therapeutics, Inc. Common Stock's floating shares are currently sold short.

Damora Therapeutics, Inc. Common Stock saw a increase in short interest in July. As of July 15th, there was short interest totaling 4,688,241 shares, an increase of 31.4% from the previous total of 3,567,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.65% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Damora Therapeutics, Inc. Common Stock: Cogent Biosciences, Inc. (10.37%), Mirum Pharmaceuticals, Inc. (13.01%), CG Oncology, Inc. (14.42%), Xenon Pharmaceuticals Inc. (6.75%), Ligand Pharmaceuticals Incorporated (10.14%), Dianthus Therapeutics, Inc. (17.39%), Oruka Therapeutics, Inc. (19.14%), PTC Therapeutics, Inc. (12.55%), Kiniksa Pharmaceuticals International, plc (12.21%), Erasca, Inc. (11.53%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling DMRA is an investing strategy that aims to generate trading profit from Damora Therapeutics, Inc. Common Stock as its price is falling. DMRA shares are trading down $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Damora Therapeutics, Inc. Common Stock occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMRA, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like DMRA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:DMRA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 7/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The ultimate IPO unicorn
Anthropic is now worth more than a trillion dollars, making it the first private company to reach that milesto...
Weiss Ratings | Sponsoredtc pixel
Trump's Next Move Could Shrink Your Dollar
There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. d...
Priority Gold | Sponsoredtc pixel
A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...
Freedom Financial | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel